Agenus shared a post on LinkedIn:
“A few great days in Chicago at ASCO 2026, connecting with experts across the field of immunotherapy, attending important scientific sessions and reconnecting with colleagues committed to advancing cancer care.
We return energized and ready to get back to the work that matters: progressing immunotherapy advances for patients with difficult-to-treat cancers.
Missed our posters or want to revisit the data? Visit the publications section of our website.”
Proceed to the video attached to the post.
More posts about ASCO 2026.